Trial Phase
Trial Status
Paid Participation
Clear All
58 Liver Fibrosis Trials Near You
Power is an online platform that helps thousands of Liver Fibrosis patients discover FDA-reviewed trials every day. Every trial we feature meets safety and ethical standards, giving patients an easy way to discover promising new treatments in the research stage.
Learn More About PowerSurvodutide for Fatty Liver Disease
Trial Details
Key Eligibility Criteria
1800 Participants Needed
Efruxifermin for NASH
Trial Details
Key Eligibility Criteria
1650 Participants Needed
Triple Combination Therapy for Cystic Fibrosis
Trial Details
Key Eligibility Criteria
174 Participants Needed
VX-121 Combination Therapy for Cystic Fibrosis
Trial Details
Key Eligibility Criteria
822 Participants Needed
VX-121 + Tezacaftor + Deutivacaftor for Cystic Fibrosis
Trial Details
Key Eligibility Criteria
210 Participants Needed
Antibiotics for Cystic Fibrosis Pulmonary Exacerbations
Trial Details
Key Eligibility Criteria
730 Participants Needed
SPL84 for Cystic Fibrosis
Trial Details
Key Eligibility Criteria
24 Participants Needed
CMTX-101 for Cystic Fibrosis
Trial Details
Key Eligibility Criteria
41 Participants Needed
VX-522 mRNA Therapy for Cystic Fibrosis
Trial Details
Key Eligibility Criteria
33 Participants Needed
Belapectin for NASH Cirrhosis
Trial Details
Key Eligibility Criteria
357 Participants Needed
Trial Details
Key Eligibility Criteria
180 Participants Needed
Pegozafermin for Liver Cirrhosis
Trial Details
Key Eligibility Criteria
762 Participants Needed
Survodutide for Fatty Liver Disease
Trial Details
Key Eligibility Criteria
1590 Participants Needed
Lanifibranor for Nonalcoholic Steatohepatitis (NASH)
Trial Details
Key Eligibility Criteria
1000 Participants Needed
Pegozafermin for Fatty Liver Disease
Trial Details
Key Eligibility Criteria
1050 Participants Needed
Atezolizumab +/− Bevacizumab for Liver Cancer
Trial Details
Key Eligibility Criteria
120 Participants Needed
Cannabidiol for Chronic Liver Injury Prevention
Trial Details
Key Eligibility Criteria
154 Participants Needed
CFTR Modulator Therapy for Cystic Fibrosis
Trial Details
Key Eligibility Criteria
64 Participants Needed
Ceftaroline for Cystic Fibrosis
Trial Details
Key Eligibility Criteria
24 Participants Needed
Imaging Biomarkers for Cystic Fibrosis
Trial Details
Key Eligibility Criteria
44 Participants Needed
Antibiotic Treatments for Cystic Fibrosis
Trial Details
Key Eligibility Criteria
430 Participants Needed
Lung Transplant Education for Cystic Fibrosis
Trial Details
Key Eligibility Criteria
132 Participants Needed
Pemafibrate for Primary Biliary Cirrhosis
Trial Details
Key Eligibility Criteria
16 Participants Needed
CFTR Modulators for Cystic Fibrosis
Trial Details
Key Eligibility Criteria
50 Participants Needed
AZD2693 for Non-alcoholic Steatohepatitis with Fibrosis
Trial Details
Key Eligibility Criteria
220 Participants Needed
PHIN-214 for Liver Cirrhosis
Trial Details
Key Eligibility Criteria
48 Participants Needed
Metabolic Surgery for Non-Alcoholic Fatty Liver Disease
Trial Details
Key Eligibility Criteria
120 Participants Needed
Glycine Buffer for Airway pH Measurement in Asthma
Trial Details
Key Eligibility Criteria
74 Participants Needed
Clinical Tool for Cystic Fibrosis Waitlist Mortality
Trial Details
Key Eligibility Criteria
10 Participants Needed
IV Bacteriophage Therapy for Cystic Fibrosis
Trial Details
Key Eligibility Criteria
73 Participants Needed
Learn More About Power
We started Power when my dad was diagnosed with multiple myeloma, and I struggled to help him access the latest immunotherapy. Hopefully Power makes it simpler for you to explore promising new treatments, during what is probably a difficult time.